AGP Executive Report
Last update: 30 minutes agoCancer Care Breakthrough: Akeso’s ivonescimab plus chemotherapy posted a statistically significant overall survival win in China’s HARMONi-6 trial for first-line advanced squamous NSCLC, beating tislelizumab+chemo (27.9 vs 23.7 months; hazard ratio 0.66), with results set for ASCO plenary. Public Health Access: Shenzhen is expanding community-based smoking cessation, screening residents at first visits and using follow-ups at day 7 and months 1/6/12; the system has supported millions of screenings and thousands of quitters. Child Protection & Mental Health: China issued new guidance for “minor protection” agencies, calling for tailored mental health support (including for autistic children), updated records for vulnerable minors, and safety checks at facilities. Workplace Safety: Five people died and one was injured after a collapse during illegal mining in Yunnan’s Huize County; authorities are investigating the cause. Disaster Response: A blast at an explosives depot in Myanmar’s Shan State killed 50+ and injured dozens near the Chinese border, with rescue teams still searching rubble. Military Medicine: China’s PLA Navy hospital ship “Silk Road Ark” sailed from Zhanjiang for a South China Sea medical mission, offering consultations, TCM physiotherapy, surgery, and drills.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
